NHS spends £26 million on consultancy
December 18, 2018Manufacturing and Production BMA, Consultancy, Jobs, NHS, health
Private consultancy firms were paid at least £26 million as part of a reorganisation of the NHS, in what has …
Celltrion and Teva’s Herceptin biosimilar secures FDA approval in breast cancer
December 18, 2018Manufacturing and Production, Sales and Marketing Herceptin, Herzuma, Teva, celltrion, pharma
Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by …
Eli Lilly’s Taltz shows superiority over AbbVie’s Humira
December 18, 2018Manufacturing and Production Eli Lilly, Humira, Taltz, arthritis, immune system
A study has found that Eli Lilly’s Taltz (ixekizumab) met the primary, and all secondary endpoints, in patients with active …
J&J announces $5bn share repurchase
December 18, 2018Manufacturing and Production J&J, JJ, Shares, asbestos, baby powder, reuters, scandal
New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released …
The Autumn 2018 edition of Pharmafile is available to read online now!
December 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunology, infectious diseases, pharma, pharmafile, rare diseases
The Autumn 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …
NHS overcrowding leads to ambulances being turned away
December 17, 2018Sales and Marketing Hopsitals, NHS, UK, health, politics
NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above …
Novartis withdraw marketing application for heart drug
December 17, 2018Sales and Marketing CHMP, EMA, MI, Novartis, pharma
Swiss multinational Novartis has withdrawn a European Medicines Agency (EMA) marketing application for canakinumab for the prevention of serious events …
CHMP approve Bristol-Myers Squibb’s Sprycel for paediatric patients with Ph+ ALL
December 17, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Sprycel, all
New Jersey-based firm Bristol -Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the …
No-deal Brexit stockpiling puts pressure on supply chain
December 17, 2018Sales and Marketing brexit, no-deal, pharma, pricing, supply chain
The stockpiling of medicines in preparation for a no-deal Brexit is putting pressure on the supply chain and causing shortages …
J&J shares plummet after asbestos cover up allegations emerge
December 17, 2018Sales and Marketing J&J, JJ, Johnson & Johnson, asbestos, reuters
Shares in American healthcare firm Johnson & Johnson plummeted on Friday after news agency Reuters reported that the New Jersey-based …
Top Ten most popular articles on Pharmafile.com this week!
December 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10
Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …
‘Significant’ health outcomes gap still exists in Scotland
December 14, 2018Medical Communications NHS, Scotland, UK, health, inequality
There is a significant gap in health outcomes between the most and least deprived areas of Scotland, a Scottish government …
Data reveals November’s performance was worst on record for NHS
December 14, 2018Medical Communications NHS, NHS England, UK, funding, investment, wait times
November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …
York-based biotech expands premises after $2.2 million investment
December 14, 2018Medical Communications UK, aptamer, biotech, funding, investment, york science park
The York-based Aptamer Group is set to expand its premises after securing $2.2 million in overseas investment in June of …
Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m
December 13, 2018Business Services GI, IBS, basuch, cnstipation, synergy pharma
Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch …
MSD announced collaboration with Brazilian non-profit over development of dengue vaccine
December 13, 2018Business Services, Medical Communications, Research and Development Dengue fever, HPV, hepatitis a, vaccines, virus
US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing …
Those living in rural areas less likely to survive cancer, study shows
December 13, 2018Medical Communications, Research and Development Cancer, health, oncology, rural, survival, urban
Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research …
Government choose England top pharmacist to address overprescribing and polypharmacy
December 13, 2018Medical Communications, Research and Development England, Matt Hancock, NHS, medicine, pharma
England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS. The move …
NICE reject two treatments for fatal, ultra-rare disease – hATTR
December 13, 2018Medical Communications, Research and Development, Sales and Marketing
The NHS’ cost effectiveness body NICE has rejected two treatments for the rare inherited condition, hereditary transthyretin-related amyliodsis (hATTR), over …
The December issue of Pharmafocus is available to read online now!
December 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma
The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
